One-year efficacy and safety of 0.1% cyclosporine a cationic emulsion in the treatment of severe dry eye disease

Baudouin C., De La Maza M.S., Amrane M., Garrigue J.-S., Ismail D., Figueiredo F.C., Leonardi A.

Affiliations

Quinze-Vingts National Ophthalmology Hospital, Paris, France; UPMC University, Paris 6, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris, France; University of Versailles Saint-Quentin en Yvelines, Versailles, France; Institute Clinic of Ophthalmology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Santen SAS, Evry, France; Department of Ophthalmology, Royal Victoria Infirmary and Newcastle University, Newcastle upon Tyne, United Kingdom; Ophthalmology Unit, Department of Neuroscience, University of Padua, Padua, Italy

Related Publications

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.